AU Patent

AU2024203155B2 — Rescue treatment of post operative nausea and vomiting

Assigned to Acacia Pharma Ltd · Expires 2025-03-13 · 1y expired

What this patent protects

Use of amisulpride in the treatment of postoperative nausea and/or vomiting (PONV) in a patient, wherein the patient has been administered with a non amisulpride prophylaxis drug for PONV at the induction of anaesthesia, wherein 5 the amisulpride is administered by IV infusion …

USPTO Abstract

Use of amisulpride in the treatment of postoperative nausea and/or vomiting (PONV) in a patient, wherein the patient has been administered with a non amisulpride prophylaxis drug for PONV at the induction of anaesthesia, wherein 5 the amisulpride is administered by IV infusion over a time period of from about 20 seconds up to about 20 minutes, and wherein the dose of amisulpride is 9.5 to 10.5 mg.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024203155B2
Jurisdiction
AU
Classification
—
Expires
2025-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Acacia Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.